P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 2,230,000 shares, a decrease of 49.1% from the January 15th total of 4,380,000 shares. Based on an average daily volume of 2,140,000 shares, the short-interest ratio is presently 1.0 days. Currently, 2.4% of the company's shares are sold short.
P3 Health Partners Trading Down 3.8 %
Shares of NASDAQ PIII traded down $0.01 during midday trading on Monday, hitting $0.23. The company's stock had a trading volume of 1,938,822 shares, compared to its average volume of 5,558,576. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 1.11. The business's 50 day moving average is $0.21 and its two-hundred day moving average is $0.34. P3 Health Partners has a 12-month low of $0.17 and a 12-month high of $1.20. The firm has a market cap of $82.53 million, a P/E ratio of -0.27 and a beta of 0.96.
Institutional Investors Weigh In On P3 Health Partners
Hedge funds and other institutional investors have recently modified their holdings of the business. Warberg Asset Management LLC raised its holdings in shares of P3 Health Partners by 1,353.5% in the fourth quarter. Warberg Asset Management LLC now owns 145,346 shares of the company's stock worth $33,000 after buying an additional 135,346 shares during the period. Sanders Morris Harris LLC increased its holdings in P3 Health Partners by 50.0% during the 4th quarter. Sanders Morris Harris LLC now owns 184,497 shares of the company's stock worth $41,000 after purchasing an additional 61,499 shares during the period. XTX Topco Ltd purchased a new position in P3 Health Partners during the 4th quarter worth $46,000. Geode Capital Management LLC raised its position in P3 Health Partners by 115.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company's stock valued at $398,000 after purchasing an additional 550,925 shares in the last quarter. Finally, Trinity Financial Advisors LLC bought a new stake in P3 Health Partners during the 4th quarter valued at $261,000. 7.75% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, TD Cowen reduced their price target on P3 Health Partners from $0.90 to $0.25 and set a "hold" rating on the stock in a report on Wednesday, November 20th.
View Our Latest Research Report on PIII
P3 Health Partners Company Profile
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
Featured Articles
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.